IVI in the Media
IVI Featured in The Korea Herald
"Developing cholera vaccine in South Korea: IVI Director General Jerome Kim shares stories behind Euvichol, Korea’s first oral cholera vaccine"
In the weekend edition of The Korea Herald is a full-page article on how IVI developed Euvichol, the oral cholera vaccine, in collaboration with EuBiologics. Euvichol was prequalified by the World Health Organization (WHO) in December, 2015. The availability of Euvichol will help double the global supply of oral cholera vaccines, which means more low-income countries will have access to this potentially life-saving vaccine.